World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
20348
World Ranking
2205
National Ranking
1067

Roland W. Herzog publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roland W. Herzog sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 322 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roland W. Herzog D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roland W. Herzog sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Roland W. Herzog is affiliated with the University of Florida in the United States. Their research spans multiple facets of biochemistry, genetics, molecular biology, and medicine, with a particular focus on applied gene therapy and immunological responses in genetic engineering contexts.

The scientist has contributed extensively to several main fields of study, including:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their research can be further categorized into several specific subfields:

  • Molecular Biology
  • Genetics
  • Oncology
  • Hematology
  • Infectious Diseases

Roland W. Herzog's main research topics include:

  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • CAR-T cell therapy research
  • Hemophilia Treatment and Research
  • RNA Interference and Gene Delivery
  • Viral Infectious Diseases and Gene Expression in Insects
  • Viral gastroenteritis research and epidemiology

Their work is documented in various leading scientific journals, with frequent publications in these venues:

  • Molecular Therapy
  • arXiv (Cornell University)
  • Blood
  • Molecular Therapy - Methods & Clinical Development
  • Human Gene Therapy

Some of the notable recent papers authored or co-authored by Roland W. Herzog include:

  • Immune Responses to Viral Gene Therapy Vectors, 2020, Molecular Therapy
  • Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models, 2021, Nature Communications
  • Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies, 2023, Journal of Clinical Investigation
  • Role of orally induced regulatory T cells in immunotherapy and tolerance, 2020, Cellular Immunology
  • Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy, 2021, Frontiers in Immunology

Roland W. Herzog has frequently collaborated with several co-authors, including:

  • Sandeep Kumar
  • Moanaro Biswas
  • Thaís B. Bertolini
  • Weidong Xiao
  • Ype P. de Jong

Best Publications

  • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

    Mark A. Kay;Catherine S. Manno;Catherine S. Manno;Margaret V. Ragni;Peter J. Larson;Peter J. Larson

  • AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

    Catherine S. Manno;Amy J. Chew;Sylvia Hutchison;Peter J. Larson

  • LONG-TERM CORRECTION OF CANINE HEMOPHILIA B BY GENE TRANSFER OF BLOOD COAGULATION FACTOR IX MEDIATED BY ADENO-ASSOCIATED VIRAL VECTOR

    Roland W. Herzog;Edmund Y. Yang;Linda B. Couto;J. Nathan Hagstrom

  • Progress and prospects: immune responses to viral vectors

    Sushrusha Nayak;Roland W. Herzog

  • Immune Responses to Viral Gene Therapy Vectors.

    Jamie L. Shirley;Ype P. de Jong;Cox Terhorst;Roland W. Herzog

  • STABLE GENE TRANSFER AND EXPRESSION OF HUMAN BLOOD COAGULATION FACTOR IX AFTER INTRAMUSCULAR INJECTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS

    R W Herzog;J N Hagstrom;S H Kung;S J Tai

  • Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.

    Li Zhong;Baozheng Li;Cathryn S. Mah;Lakshmanan Govindasamy

  • Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

    Federico Mingozzi;Yi-Lin Liu;Eric Dobrzynski;Antje Kaufhold

  • Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.

    Jane D. Mount;Roland W. Herzog;D. Michael Tillson;Susan A. Goodman

  • Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.

    Glenn P. Niemeyer;Glenn P. Niemeyer;Roland W. Herzog;Jane Mount;Valder R. Arruda

  • Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression

    Li Zhong;Baozheng Li;Giridhararao Jayandharan;Cathryn S. Mah

  • Clinical development of gene therapy: results and lessons from recent successes.

    Sandeep Rp Kumar;David M Markusic;Moanaro Biswas;Katherine A High

  • Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation

    Roland W. Herzog;Jane D. Mount;Valder R. Arruda;Katherine A. High

  • The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver

    Ashley T. Martino;Masataka Suzuki;David M. Markusic;Irene Zolotukhin

  • Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.

    Ou W. Cao;Eric Dobrzynski;Lixin Wang;Sushrusha Nayak

  • Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver

    Hiroyuki Nakai;Roland W. Herzog;J. Nathan Hagstrom;Johannes Walter

  • Treatment of human disease by adeno-associated viral gene transfer

    Kenneth H. Warrington;Roland W. Herzog

  • Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.

    Valder R. Arruda;Paul A. Fields;Ross Milner;Luanne Wainwright

  • Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy

    Roland W. Herzog;Paul A. Fields;Valder R. Arruda;Jeff O. Brubaker

  • Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

    Valder R. Arruda;Joerg Schuettrumpf;Roland W. Herzog;Timothy C. Nichols

Frequent Co-Authors

Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Cox Terhorst
Cox Terhorst Beth Israel Deaconess Medical Center
Barry J. Byrne
Barry J. Byrne University of Florida
Henry Daniell
Henry Daniell University of Pennsylvania
Valder R. Arruda
Valder R. Arruda University of Pennsylvania
Federico Mingozzi
Federico Mingozzi Children's Hospital of Philadelphia
Arun Srivastava
Arun Srivastava University of Florida
Sergei Zolotukhin
Sergei Zolotukhin University of Florida
Mark A. Kay
Mark A. Kay Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing programs, such as Licensed Practical Nurse (LPN) schools, often serve as accessible entry points. If you’re curious about entry options, reviews of lpn schools easy to get into provide valuable insights on programs with flexible admission criteria.

Advancing beyond LPN, becoming a Nurse Practitioner (NP) is a significant step. If you’re aiming for a seamless transition, the which nurse practitioner program is easiest guide highlights programs that balance curriculum requirements with student support, making them less intimidating for newcomers.

Specializing as a Psychiatric-Mental Health Nurse Practitioner (PMHNP) is another promising path, especially for those passionate about immunology’s role in neurological and psychiatric conditions. To ensure practical experience, candidates should consider online pmhnp programs with clinical placement, which facilitate hands-on learning in healthcare settings.

Finally, affordability is crucial when selecting a program. Exploring cheapest online pmhnp programs helps balance cost with quality education, making advanced healthcare degrees more accessible to a wider audience.

Best Scientists Citing Roland W. Herzog

Trending Scientists

Recently Published Articles